MILESTONE PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 USD | +1.95% |
|
-3.68% | -5.99% |
Chart calendar Milestone Pharmaceuticals Inc.
a0fc4cd6ea07e8.rZ5g59vc-syWA5nuzSzDYY7djDlEKSiGZZfRbpfNb0k.4e8qv4mvm_jvMvKPuEOKU_6T7kMIQnHKAaWJOvOmGCiU1VOp9re_-9M21A~a9ed172663ee7043c43c658e4652eedb
Upcoming events on Milestone Pharmaceuticals Inc.
Past events on Milestone Pharmaceuticals Inc.
| 2024-04-18 05:30 pm | Cardiovascular Nursing Symposium - Richard L. Sherwood |
| 2024-04-18 05:30 pm | Cardiovascular Nursing Symposium - Kathryn A. Wood |
| 2024-04-18 05:30 pm | Cardiovascular Nursing Symposium - James Nunez |
| 2024-04-10 08:45 am | Needham Healthcare Conference |
| 2024-03-21 07:14 am | Q4 2023 Earnings Release |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2023-11-28 | GCFF Virtual Healthcare Conference |
| 2023-11-28 10:30 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-13 08:00 am | Q3 2023 Earnings Call |
| 2023-11-13 06:57 am | Q3 2023 Earnings Release |
| 2023-11-11 09:57 am | American Heart Association Scientific Meeting |
| 2023-09-12 09:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-10 07:35 am | Q2 2023 Earnings Release |
| 2023-06-09 08:30 am | Jefferies Global Healthcare Conference |
| 2023-06-07 11:00 am | Annual General Meeting |
| 2023-05-22 08:00 am | Investor Meeting - Key Opinion Leader |
| 2023-05-19 04:00 pm | Heart Rhythm Meeting |
| 2023-05-11 07:16 am | Q1 2023 Earnings Release |
| 2023-04-19 03:45 pm | Needham Healthcare Conference |
| 2023-03-29 09:17 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 15,0 15,0 0% | 5,00 1,60 212.5% | 1,00 1,00 0% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -57,8 -46,8 -23.6% | -50,6 -54,1 6.45% | -43,0 -40,5 -6.12% | -59,6 -62,9 5.32% | -61,0 -62,7 2.7% | -54,2 |
|
EBIT Million USD | Released Forecast Spread | -57,9 -52,2 -10.78% | -50,7 -55,5 8.69% | -43,1 -41,6 -3.51% | -59,6 -62,6 4.72% | -61,1 -61,4 0.57% | -61,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -55,3 -49,7 -11.16% | -50,0 -54,8 8.78% | -42,9 -41,3 -3.65% | -58,4 -61,9 5.68% | -59,7 -59,6 -0.17% | -59,7 |
|
Net income Million USD | Released Forecast Spread | -55,2 -49,7 -11.19% | -50,0 -54,8 8.81% | -42,9 -41,3 -3.65% | -58,4 -61,9 5.68% | -59,7 -59,6 -0.17% | -59,7 |
|
EPS USD | Released Forecast Spread | -3,50 -3,05 -14.66% | -1,70 -1,94 12.48% | -1,02 -1,06 3.77% | -1,38 -1,43 3.63% | -1,39 -1,37 -1.46% | -1,15 |
| Announcement Date | 06/03/20 | 29/03/21 | 24/03/22 | 29/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,50 0,00 - | 3,50 0,70 400% | 1,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,77 |
|
EBITDA Million USD | Released Forecast Spread | -16,9 -14,4 -17.33% | -14,0 -17,0 17.51% | -16,8 -14,4 -16.54% | -15,0 -16,2 7.39% | -13,7 -17,0 19.15% | -15,5 -16,5 6.16% | -16,4 -15,3 -7.27% | -15,3 -16,8 8.71% | -13,8 -15,4 10.56% | -12,8 | -13,0 | -13,7 | -14,9 | |
|
EBIT Million USD | Released Forecast Spread | -16,9 -15,4 -9.57% | -14,0 -17,4 19.39% | -16,8 -14,7 -14.23% | -15,0 -17,4 13.82% | -13,8 -15,7 12.08% | -15,5 -17,4 11.11% | -16,4 -16,7 1.82% | -15,4 -16,7 7.8% | -13,8 -14,2 2.47% | -13,0 | -13,9 | -15,2 | -19,0 | -20,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -15,4 -9.84% | -14,0 -17,4 19.47% | -16,6 -14,7 -13.42% | -14,6 -17,4 16.32% | -13,2 -15,5 15.12% | -15,0 -17,2 13.28% | -16,0 -16,7 3.82% | -15,1 -16,4 8.1% | -13,6 -13,9 2.18% | -12,9 | -13,8 | -15,1 | -18,9 | -20,9 |
|
Net income Million USD | Released Forecast Spread | -16,9 -15,4 -9.84% | -14,0 -17,4 19.47% | -16,6 -14,7 -13.42% | -14,6 -17,4 16.32% | -13,2 -15,5 15.12% | -15,0 -17,2 13.28% | -16,0 -16,7 3.82% | -15,1 -16,4 8.1% | -13,6 -13,9 2.18% | -12,9 | -13,8 | -15,1 | -18,9 | -20,9 |
|
EPS USD | Released Forecast Spread | -0,40 -0,36 -9.89% | -0,33 -0,39 15.38% | -0,39 -0,36 -8.33% | -0,34 -0,41 16.67% | -0,31 -0,34 8.82% | -0,35 -0,40 12.06% | -0,37 -0,39 4.15% | -0,35 -0,38 8.38% | -0,32 -0,31 -2.4% | -0,26 | -0,26 | -0,29 | -0,37 | -0,34 |
| Announcement Date | 24/03/22 | 12/05/22 | 10/08/22 | 10/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 13/11/23 | 21/03/24 | - | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Milestone Pharmaceuticals Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MIST Stock
- Calendar Milestone Pharmaceuticals Inc.
